• Made available online as an Accepted Preprint 15 April 2011

Signalling by insulin and IGF receptors: supporting acts and new players

  1. Kenneth Siddle
  1. Department of Clinical Biochemistry, Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories, Cambridge CB2 0QQ, UK
  1. (Correspondence should be addressed to K Siddle; Email: ks14{at}mole.bio.cam.ac.uk)


The signalling pathways utilised by insulin receptor (IR) and IGF receptor to transduce their diverse effects on cellular metabolism, growth and survival are well established in broad outline, but many details remain to be elucidated. Tyrosine phosphorylation of IR substrates and Shc initiates signalling via canonical phosphoinositide 3-kinase/Akt and Ras/MAP kinase pathways, which together mediate many of the actions of insulin and IGFs. However, a variety of additional substrates and scaffolds have been described that may play roles in modulating the canonical pathways or in specific biological responses. This review will focus on recent studies that have extended our understanding of insulin/IGF signalling pathways, and the elements that may contribute to specificity.

  • Revision received 17 March 2011
  • Accepted 15 April 2011
| Table of Contents